{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:28:05Z","timestamp":1768570085722,"version":"3.49.0"},"posted":{"date-parts":[[2025,3,13]]},"group-title":"Cardiovascular Medicine","reference-count":47,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,3,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure, and death. Recent studies suggests that individuals with early onset of AF could be at increased risk of developing heart failure and dilated cardiomyopathy. This study aimed to identifying genetic variants in a broad panel of cardiomyopathy genes among early-onset AF individuals.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted targeted genetic sequencing of 29 cardiomyopathy-associated genes in 478 individuals with AF onset below 45 years of age from a Danish cohort. Additionally, we analyzed whole exome sequencing data in 374,289 individuals from the UK Biobank, including 29,108 individuals with AF. The cohort was stratified by age at AF diagnosis, and individuals with pre-existing cardiomyopathy were excluded. We focused on rare, truncating variants predicted to lead to loss of function, and potentially deleterious missense variants in the UK Biobank.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the Danish cohort, 42 (8.8%) individuals with early-onset AF had truncating genetic variants in known cardiomyopathy genes. The UK Biobank analysis showed an inverse dose-response-like relationship between age of AF onset and prevalence of truncating variants, ranging from 3.8% in the AF onset &lt;45 years group to 1.4% in the group without AF diagnosis. The prevalence of rare missense variants showed a similar pattern.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We identified a high prevalence of deleterious variants in cardiomyopathy-associated genes among individuals with early-onset AF. This supports recent guideline suggestions and indicates that genetic testing and surveillance for cardiomyopathy could be relevant in selected individuals with an early AF diagnosis.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.03.12.25323872","type":"posted-content","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:20:21Z","timestamp":1741886421000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of deleterious cardiomyopathy variants in early-onset atrial fibrillation"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8460-8696","authenticated-orcid":false,"given":"Quim","family":"Bech Vilaseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8416-0543","authenticated-orcid":false,"given":"Oliver Bundgaard","family":"Vad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-544X","authenticated-orcid":false,"given":"Christian","family":"Paludan-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4732-4921","authenticated-orcid":false,"given":"Laura","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-5322","authenticated-orcid":false,"given":"Morten Salling","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-8515","authenticated-orcid":false,"given":"Jesper Hastrup","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-1844","authenticated-orcid":false,"given":"Pia Rengtved","family":"Lundegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025032002531402000_2025.03.12.25323872v1.1","doi-asserted-by":"crossref","unstructured":"Vinter N , Cordsen P , Johnsen SP , Staerk L , Benjamin EJ , Frost L , et al. Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study. BMJ. 2024 Apr 17;e077209.","DOI":"10.1136\/bmj-2023-077209"},{"key":"2025032002531402000_2025.03.12.25323872v1.2","doi-asserted-by":"crossref","unstructured":"Odutayo A , Wong CX , Hsiao AJ , Hopewell S , Altman DG , Emdin CA . Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016 Sep 6;i4482.","DOI":"10.1136\/bmj.i4482"},{"issue":"24","key":"2025032002531402000_2025.03.12.25323872v1.3","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/eurheartj\/ehae216","article-title":"Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality","volume":"45","year":"2024","journal-title":"European Heart Journal"},{"issue":"2","key":"2025032002531402000_2025.03.12.25323872v1.4","first-page":"163","article-title":"Loss of Cardiac Splicing Regulator RBM20 Is Associated With Early-Onset Atrial Fibrillation","volume":"9","year":"2024","journal-title":"JACC: Basic to Translational Science"},{"issue":"8","key":"2025032002531402000_2025.03.12.25323872v1.5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamacardio.2024.1528","article-title":"Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk","volume":"9","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2025032002531402000_2025.03.12.25323872v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.3370"},{"issue":"7","key":"2025032002531402000_2025.03.12.25323872v1.7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamacardio.2022.0810","article-title":"Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes","volume":"7","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025032002531402000_2025.03.12.25323872v1.8","doi-asserted-by":"crossref","unstructured":"Joglar JA , Chung MK , Armbruster AL , Benjamin EJ , Chyou JY , Cronin EM , et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2024 Jan 2 [cited 2025 Feb 20];149(1). Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000001193","DOI":"10.1161\/CIR.0000000000001207"},{"key":"2025032002531402000_2025.03.12.25323872v1.9","doi-asserted-by":"publisher","DOI":"10.3109\/14017431.2012.673728"},{"key":"2025032002531402000_2025.03.12.25323872v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp698"},{"key":"2025032002531402000_2025.03.12.25323872v1.11","doi-asserted-by":"crossref","unstructured":"Van Der Auwera GA , Carneiro MO , Hartl C , Poplin R , Del Angel G , Levy-Moonshine A , et al. From FastQ Data to High-Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline. CP in Bioinformatics [Internet]. 2013 Oct [cited 2025 Feb 20];43(1). Available from: https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/10.1002\/0471250953.bi1110s43","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"2025032002531402000_2025.03.12.25323872v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06618-y"},{"key":"2025032002531402000_2025.03.12.25323872v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx246"},{"key":"2025032002531402000_2025.03.12.25323872v1.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779"},{"key":"2025032002531402000_2025.03.12.25323872v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-021-04103-Z"},{"key":"2025032002531402000_2025.03.12.25323872v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2018.03.004"},{"key":"2025032002531402000_2025.03.12.25323872v1.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.053033"},{"issue":"7","key":"2025032002531402000_2025.03.12.25323872v1.18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamacardio.2022.1061","article-title":"Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank","volume":"7","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"3","key":"2025032002531402000_2025.03.12.25323872v1.19","first-page":"e003273","article-title":"International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework","volume":"14","year":"2021","journal-title":"Circ: Genomic and Precision Medicine"},{"issue":"4","key":"2025032002531402000_2025.03.12.25323872v1.20","doi-asserted-by":"crossref","first-page":"100012","DOI":"10.1016\/j.gim.2023.100012","article-title":"Cardiomyopathy prevalence exceeds 30% in individuals with TTN variants and early atrial fibrillation","volume":"25","year":"2023","journal-title":"Genetics in Medicine"},{"key":"2025032002531402000_2025.03.12.25323872v1.21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.1.308"},{"key":"2025032002531402000_2025.03.12.25323872v1.22","doi-asserted-by":"publisher","DOI":"10.4161\/fly.19695"},{"key":"2025032002531402000_2025.03.12.25323872v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2018.12.015"},{"key":"2025032002531402000_2025.03.12.25323872v1.24","unstructured":"RStudio Team. RStudio: Integrated Development Environment for R [Internet]. Boston, MA: RStudio, PBC.; 2020. Available from: http:\/\/www.rstudio.com\/"},{"key":"2025032002531402000_2025.03.12.25323872v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07556-0"},{"issue":"11","key":"2025032002531402000_2025.03.12.25323872v1.26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/CIRCRESAHA.122.319835","article-title":"Arrhythmias as Presentation of Genetic Cardiomyopathy","volume":"130","year":"2022","journal-title":"Circulation Research"},{"key":"2025032002531402000_2025.03.12.25323872v1.27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jprot.2016.07.020","article-title":"Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy","volume":"148","year":"2016","journal-title":"Journal of Proteomics"},{"key":"2025032002531402000_2025.03.12.25323872v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20114-9"},{"key":"2025032002531402000_2025.03.12.25323872v1.29","unstructured":"McNally EM , Mestroni L . Dilated Cardiomyopathy."},{"key":"2025032002531402000_2025.03.12.25323872v1.30","doi-asserted-by":"crossref","unstructured":"Paludan-M\u00fcller C , Larsen S , Ahlberg G , Andreasen L , Monfort LM , Svendsen JH , et al. Clinical Implications of SCN10A Loss-of-Function Variants in 169 610 Exomes Representing the General Population. Circ: Genomic and Precision Medicine [Internet]. 2022 Feb [cited 2025 Feb 27];15(1). Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCGEN.121.003574","DOI":"10.1161\/CIRCGEN.121.003574"},{"issue":"13","key":"2025032002531402000_2025.03.12.25323872v1.31","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.3390\/ijms241310510","article-title":"An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy","volume":"24","year":"2023","journal-title":"IJMS"},{"key":"2025032002531402000_2025.03.12.25323872v1.32","doi-asserted-by":"publisher","DOI":"10.1086\/509044"},{"key":"2025032002531402000_2025.03.12.25323872v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3719"},{"key":"2025032002531402000_2025.03.12.25323872v1.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18179"},{"key":"2025032002531402000_2025.03.12.25323872v1.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.039573"},{"issue":"1","key":"2025032002531402000_2025.03.12.25323872v1.36","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1038\/s41598-024-56154-7","article-title":"Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies","volume":"14","year":"2024","journal-title":"Sci Rep"},{"key":"2025032002531402000_2025.03.12.25323872v1.37","doi-asserted-by":"crossref","unstructured":"Akhtar MM , Lorenzini M , Cicerchia M , Ochoa JP , Hey TM , Sabater Molina M , et al. Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene. Circ: Heart Failure [Internet]. 2020 Oct [cited 2025 Feb 20];13(10). Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCHEARTFAILURE.119.006832","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832"},{"key":"2025032002531402000_2025.03.12.25323872v1.38","doi-asserted-by":"crossref","unstructured":"Hermida A , Ader F , Millat G , Jedraszak G , Maury P , Cador R , et al. NEXN Gene in Cardiomyopathies and Sudden Cardiac Deaths: Prevalence, Phenotypic Expression, and Prognosis. Circ: Genomic and Precision Medicine [Internet]. 2024 Feb [cited 2025 Feb 20];17(1). Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCGEN.123.004285","DOI":"10.1161\/CIRCGEN.123.004285"},{"key":"2025032002531402000_2025.03.12.25323872v1.39","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab424"},{"issue":"1","key":"2025032002531402000_2025.03.12.25323872v1.40","first-page":"134","article-title":"Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies","volume":"12","year":"2024","journal-title":"JACC: Heart Failure"},{"key":"2025032002531402000_2025.03.12.25323872v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.205"},{"key":"2025032002531402000_2025.03.12.25323872v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.016"},{"key":"2025032002531402000_2025.03.12.25323872v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(03)00142-2"},{"key":"2025032002531402000_2025.03.12.25323872v1.44","doi-asserted-by":"crossref","unstructured":"Carruth ED , Qureshi M , Alsaid A , Kelly MA , Calkins H , Murray B , et al. Loss-of-Function FLNC Variants Are Associated With Arrhythmogenic Cardiomyopathy Phenotypes When Identified Through Exome Sequencing of a General Clinical Population. Circ: Genomic and Precision Medicine [Internet]. 2022 Aug [cited 2025 Feb 20];15(4). Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCGEN.121.003645","DOI":"10.1161\/CIRCGEN.121.003645"},{"key":"2025032002531402000_2025.03.12.25323872v1.45","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-018-0437-0"},{"issue":"6","key":"2025032002531402000_2025.03.12.25323872v1.46","first-page":"102236","article-title":"ATTR Gene Variants in HCM","volume":"29","year":"2024","journal-title":"JACC: Case Reports"},{"key":"2025032002531402000_2025.03.12.25323872v1.47","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24004"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.03.12.25323872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:30:49Z","timestamp":1768509049000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.03.12.25323872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1101\/2025.03.12.25323872","relation":{},"subject":[],"published":{"date-parts":[[2025,3,13]]},"subtype":"preprint"}}